Gilead TV Spot, 'Press Play'
Gilead TV Spot, 'Press Play'
Aug 4, 2022
iSpot.tv
Gilead Sciences, China's Qinhao Pharmaceutical Sign Global Deal for Tumor Therapy Candidate
Gilead Sciences, China's Qinhao Pharmaceutical Sign Global Deal for Tumor Therapy Candidate
2 months ago
marketscreener.com
Gilead Sciences, Inc. Stock (GILD) - Quote Nasdaq- MarketScreener
Gilead Sciences, Inc. Stock (GILD) - Quote Nasdaq- MarketScreener
Aug 18, 2020
marketscreener.com
Gilead Sciences: Global Health and Access
Gilead Sciences: Global Health and Access
Sep 17, 2024
gilead.com
Gilead Sciences | LinkedIn
Gilead Sciences | LinkedIn
Dec 13, 2024
linkedin.com
The pharmaceutical giant Gilead has created a groundbreaking new drug, Lenacapavir. It’s a twice yearly injection, proven to be 100% effective against HIV. Although Gilead hasn't told us how much they spent developing or purchasing the drug, researchers say Gilead's price point means many of the low and middle income countries that could benefit most won't be able to afford it. In a statement Gilead said: To reach as many individuals who need or want pre-exposure prophylaxis (PrEP) as quickly as
3:18
The pharmaceutical giant Gilead has created a groundbreaking new drug, Lenacapavir. It’s a twice yearly injection, proven to be 100% effective against HIV. Although Gilead hasn't told us how much they spent developing or purchasing the drug, researchers say Gilead's price point means many of the low and middle income countries that could benefit most won't be able to afford it. In a statement Gilead said: To reach as many individuals who need or want pre-exposure prophylaxis (PrEP) as quickly as
1.8K viewsJul 23, 2024
FacebookChannel 4 News
In our new series, 8 in 8, we’re taking you behind the scenes to see what a Gilead scientist does in a day. Meet Michael Gonzalez who’s studying macrophages, immune cells that tumors can use to their advantage. He works to turn blood donations into lab-grown macrophages and reprogram them to fight cancer instead of fueling it. In eight moments over eight hours, he’s helping bring us closer to discovering and developing life-changing therapies. And having a little fun along the way. #GileadLife |
2:10
In our new series, 8 in 8, we’re taking you behind the scenes to see what a Gilead scientist does in a day. Meet Michael Gonzalez who’s studying macrophages, immune cells that tumors can use to their advantage. He works to turn blood donations into lab-grown macrophages and reprogram them to fight cancer instead of fueling it. In eight moments over eight hours, he’s helping bring us closer to discovering and developing life-changing therapies. And having a little fun along the way. #GileadLife |
25K views7 months ago
FacebookGilead Sciences
0:51
Guided by our long-standing commitment to the region and the communities we serve, we’re proud of the collective impact our teams make every day, which continue to help shape the Bay Area through scientific innovation, economic contribution and community partnerships. ​ In recognition of that leadership and influence, the San Francisco Business Times named Daniel O’Day, Chairman and CEO, to its Newsmakers 100 list. Gilead congratulates all the SFBT Newsmakers leaders who are shaping the Bay Area
18.5K views2 months ago
FacebookGilead Sciences
1:05
At Gilead, patients are at the heart of everything we do – and we’re focused on developing and delivering innovative therapies across virology, oncology and inflammatory diseases. As we gather today for our annual Science Day, learn why our researchers are passionate about the work they do. #GileadLife | Gilead Sciences
47.4K viewsSep 12, 2024
FacebookGilead Sciences
0:21
At Gilead, we innovate for impact. This commitment helps us drive scientific solutions forward, reach more people in more places and protect the planet we all share. Read our 2024 Responsible Business and Impact Report to see how we’re driving change and working toward our vision to create a healthier world for all people. https://gilead.inc/3Eu4JHC #GileadLife | Gilead Sciences
25.6K viewsApr 22, 2025
FacebookGilead Sciences
Gilead TV Spot, 'HIV: March'
4 months ago
iSpot.tv
0:16
Our Building 324 is no ordinary research building. It’s a space built through the collaboration of scientists, architects, engineers and employees – and it has just received a 2021 Facility of the Year Award from the International Society for Pharmaceutical Engineering. See how we’re building collaborative, environmentally sustainable and operationally agile workspaces that inspire innovation: https://bit.ly/3eGJ5PA | Gilead Sciences
43.1K viewsApr 27, 2021
FacebookGilead Sciences
2:21
At Gilead, we set and achieve bold ambitions in our fight against the world’s most devastating diseases. In this installment of The Centrifuge Sessions, See Phan, Vice President, Oncology Clinical Development, discusses Gilead’s approach to cancer research and how his team is working to deliver innovative therapies that offer new hope for patients. | Gilead Sciences
31.1K viewsApr 10, 2025
FacebookGilead Sciences
0:28
These are Gilead scientists. They’re not just experts in oncology, virology and inflammation: They’re relentless thinkers with an unwavering commitment to discovery. Here, in our labs, every intricate step, reset and do-over plays a critical role in helping set and achieve bold ambitions in our fight against the world’s most devastating diseases. #GileadLife | Gilead Sciences
93.8K views8 months ago
FacebookGilead Sciences
2:38
Gilead Sciences earnings top estimates, boosts full-year outlook
10.1K views9 months ago
YahooYahoo Finance Video
10:36
Gilead Sciences: What to know about the biopharma company working for a coronavirus cure
May 7, 2020
Fox BusinessAnn Schmidt
0:47
“Every minute, every hour, every day that we work brings a medicine closer and closer to being available for patients.” A new video series showcases the accomplished, imaginative and dedicated individuals who have committed their careers to helping drive innovation and improve human health. In the first installment, Gilead’s Daejin Abidoye and Oriana Wiklund discuss their shared goal of advancing cancer treatments and shed light on what it’s like working here. https://bit.ly/3Er0cQo | Gilead Sci
574 viewsOct 28, 2021
FacebookGilead Sciences
1:18
Gilead is developing inhaled remdesivir
Jun 2, 2020
YahooReuters Videos
1:35
Gilead Sciences helped transform hepatitis C treatment and developed breakthrough treatments in HIV - and they’re just getting started. They’re committed to tackling today’s toughest health challenges, from HIV to cancer, while fueling local economies and creating cutting-edge research jobs. Their $32B investment in manufacturing and R&D facilities in the U.S. will power the next generation of treatments for patients while supporting local economies and skilled workers. Hear more from CEO Daniel
130 views4 months ago
FacebookPhRMA
0:26
#PrimaryBiliaryCholangitis (PBC) is a rare, chronic autoimmune disease that damages the liver’s bile ducts. We’re committed to advancing transformative care for people with PBC. | Gilead Sciences
893K viewsJul 26, 2024
FacebookGilead Sciences
3:11
Gilead Sciences posts mixed Q1 results
Apr 24, 2025
Yahoo
0:20
Gilead CEO Daniel O’Day breaks down the company's new twice-a-year HIV drug. Watch the full video here: https://cnb.cx/3WeR4Hm | CNBC
1.2K viewsJan 12, 2023
FacebookCNBC
0:27
“The first step is building trust in our community and getting people to freely talk about or engage with us about what their needs are, and how we can be a resource for them.” Meet the Gilead oncology grantee that's advancing health equity and addressing barriers to cancer care in Alabama’s Black Belt communities with the highest needs: https://gilead.inc/3FtMsqT | Gilead Sciences
110.6K viewsOct 24, 2023
FacebookGilead Sciences
0:32
Scientific progress is measured in more than data points. It’s measured in the people reached, the questions answered and the impact made. From diverse clinical trials to advances in virology, oncology and inflammation, these numbers reflect the real-world progress behind our work. Because at Gilead, we innovate for impact. Read more in our 2024 Responsible Business and Impact Report: https://gilead.inc/3Eu4JHC | Gilead Sciences
38.1K views10 months ago
FacebookGilead Sciences
7:09
Gilead Sciences CEO on FDA approval of Yeztugo: A milestone moment in the history of HIV
10 months ago
MSNCNBC
0:24
Five years of Gilead’s COMPASS Initiative, five voices from our grantee community. COMPASS is amplifying the stories of our grantees to recognize and celebrate the impact they’re having on the ground to change conversations, strengthen communities and help end the HIV epidemic in the U.S. South. In the second video of this series, we’re highlighting Transinclusive Group from South Florida, which provides resources—including in-home HIV Testing, HIV prevention education and other essential suppor
321 viewsJun 29, 2023
FacebookGilead Sciences
2:32
Take a spin through the latest in Gilead’s science and innovation in our new series, The Centrifuge Sessions. Today we sit down with Barry Crittenden, Executive Director of Clinical Development, to discuss how Gilead is helping make an impact for people living with primary biliary cholangitis (PBC), a rare autoimmune disease that affects the liver. | Gilead Sciences
383 viewsFeb 13, 2025
FacebookGilead Sciences
0:11
As a practicing physician and long-time cancer researcher, Gilead’s See Phan is all too familiar with the need for innovative new treatment options – especially in HR /HER2- breast cancer. Here, he highlights the work underway at Gilead Oncology, where the vision is to help bring more life to people with the disease. https://gilead.inc/3HvFkfd | Gilead Sciences
308 viewsJan 25, 2023
FacebookGilead Sciences
0:46
We’re paving the way for the future pipeline in oncology and inflammation with a new state-of-the-art Research Center that’s under construction. Take a hard hat tour with us to learn what makes the new labs so unique and how it’s part of Gilead’s bigger investment in U.S. manufacturing and R&D capabilities. gilead.inc/3UZtK1Z | Gilead Sciences
178 views8 months ago
FacebookGilead Sciences
0:35
Through innovation, growth and impact, our vision is to create a healthier world for all people. Read our 2023 ESG Impact Report and see how we’re driving positive change through every aspect of our business. www.gilead.com #GileadForGood | Gilead Sciences
239.4K viewsApr 18, 2024
FacebookGilead Sciences
See more